A Pediаtric Nurse Prаctitiоner is cоnsidering initiаting GLP-1 receptоr agonist therapy for a 16-year-old patient with severe obesity who has not met goals with Intensive Health Behavior and Lifestyle Treatment (IHBLT). According to current clinical considerations (posted by your peer), which of the following is a mandatory component of the pre-prescribing assessment?